MIRUM PHARMACEUTICALS INC's ticker is MIRM and the CUSIP is 604749101. A total of 160 filers reported holding MIRUM PHARMACEUTICALS INC in Q3 2023. The put-call ratio across all filers is 1.01 and the average weighting 0.4%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2023 | $3,356,141 | +91.9% | 106,207 | +57.1% | 0.00% | +200.0% |
| Q2 2023 | $1,748,502 | +154.6% | 67,588 | +136.4% | 0.00% | 0.0% |
| Q1 2023 | $686,660 | +78.3% | 28,587 | +44.7% | 0.00% | – |
| Q4 2022 | $385,184 | -74.2% | 19,753 | -72.2% | 0.00% | -100.0% |
| Q3 2022 | $1,492,000 | +68.2% | 71,009 | +55.8% | 0.00% | +100.0% |
| Q2 2022 | $887,000 | +233.5% | 45,570 | +276.7% | 0.00% | – |
| Q1 2022 | $266,000 | -10.7% | 12,098 | -35.1% | 0.00% | – |
| Q4 2021 | $298,000 | -24.7% | 18,653 | -6.1% | 0.00% | – |
| Q3 2021 | $396,000 | +65.0% | 19,865 | +43.2% | 0.00% | – |
| Q2 2021 | $240,000 | -64.2% | 13,874 | -59.0% | 0.00% | -100.0% |
| Q1 2021 | $671,000 | +15.3% | 33,874 | +1.6% | 0.00% | 0.0% |
| Q4 2020 | $582,000 | +168.2% | 33,333 | +276.9% | 0.00% | – |
| Q4 2019 | $217,000 | – | 8,843 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Frazier Life Sciences Management, L.P. | 6,470,392 | $204,464,387 | 13.58% |
| NEA Management Company, LLC | 2,186,243 | $69,085,279 | 5.34% |
| TANG CAPITAL MANAGEMENT LLC | 1,137,107 | $35,932,581 | 5.07% |
| BOONE CAPITAL MANAGEMENT LLC | 389,791 | $12,317,396 | 3.89% |
| Highlander Partners, L.P. | 122,980 | $3,886,168 | 3.84% |
| BVF INC/IL | 4,370,024 | $138,092,758 | 3.72% |
| Prosight Management, LP | 353,508 | $11,170,853 | 3.54% |
| Novo Holdings A/S | 1,500,000 | $47,400,000 | 3.50% |
| Nicholas Investment Partners, LP | 1,199,366 | $37,899,966 | 2.83% |
| Eventide Asset Management | 3,958,579 | $125,091,097 | 2.25% |